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ACID-BASE DISORDERS1
A low pH is referred to as aci-
daemia, and for practical purposes
severe acidaemia may be defined as
a pH < 7.2 (normal range: 7.35 -
7.45).
Metabolic acidosis
Metabolic acidosis is a condition
characterised by a low arterial pH
and a reduced plasma HCO3- con-
centration, and is usually accompa-
nied by compensatory alveolar
hyperventilation, resulting in a
decreased PaCO2. Severe metabol-
ic acidosis also implies a plasma
bicarbonate concentration of 8
mmol/l or lower. Major adverse
consequences of severe acidaemia
include decreased cardiac output,
decreased arterial blood pressure,
reduction in the threshold for 
cardiac dysrhythmias, and a
decrease in hepatic and renal blood
flow. Acidaemia causes potassium
to leave cells, resulting in hyper-
kalaemia. Brain metabolism and
the regulation of its volume are
impaired, resulting in progressive
central nervous system depression
and coma.1
The anion gap (unmeasured
anions) is a valuable calculation in
the differential diagnosis of meta-
bolic acidosis. This gap (some-
thing of a misnomer) refers to the
difference between the concentra-
tion of cations other than Na+, and
the concentration of anions other
than Cl- and HCO3-, in the plasma.
Usually, the unmeasured anions
exceed the unmeasured cations.
The normal anion gap is 
-8 - 16 mmol/l (since the pH of the
serum is 7.4). It is increased when
the plasma concentration of organic
anions, such as lactate or foreign
ions, accumulates in blood. The
anion gap is increased in cases of
ketoacidosis, lactic acidosis, and
other forms of acidosis in which
organic anions are increased.
Causes of a high anion gap
metabolic acidosis3,4
• Renal failure.
• Diabetic ketoacidosis and alco-
holic ketoacidosis.
• Profuse fluid losses leading to loss
of bicarbonate from the digestive
tract (as in severe diarrhoea).
• Lactic acidosis. Two types are
recognised, i.e. type A, where
there is evidence of impaired tis-
sue oxygenation, and type B,
where no such evidence is
apparent. Most cases of type A
lactic acidosis are caused by tis-
sue hypoxia arising from circula-
tory failure. In poisoned
patients type A lactic acidosis
may occur nonspecifically owing
to impairment of cardiorespira-
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Disturbances of water, electrolyte
and acid-base metabolism in acute
poisoning
Disturbances of water, electrolyte and acid-base metabolism
may develop as a result of a direct effect of poisons on 
metabolic systems, or indirectly as a result of an effect of the
poison on cardiorespiratory, gastrointestinal, hepatic, or renal
function.
Acidaemia causes
potassium to leave
cells, resulting in
hyperkalaemia.
Brain metabolism
and the regulation
of its volume are
impaired, resulting
in progressive cen-
tral nervous system
depression and
coma.
The anion gap can be calculated
as follows:2
Anion gap = [Na+] - ([HCO3-] +
[Cl-]) 
Normal range: 8 to 16 mmol/l
E.g.: Anion gap =  140 - (26 +
106) = 8 mmol/l
(Note: Clinicians should con-
sult their particular laboratory’s
reference ranges when assessing
the anion gap, as some may
include the [K+] in the above
formula.)
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tory function (e.g. as a result of
seizures), or more specifically
where the oxygen-carrying
capacity of blood is impaired
(e.g. as in carboxyhaemoglobi-
naemia or methaemoglobi-
naemia). Type B lactic acidosis
occurs with poisons that directly
inhibit mitochondrial enzymes
(as in cyanide poisoning).
Therapy should focus primarily
on securing adequate tissue oxy-
genation and on identifying and
treating the underlying cause.
Improvement of tissue oxygena-
tion may require ventilatory
support, maintenance of a high
inspired oxygen fraction, reple-
tion of extracellular fluid, after-
load reducing agents and
inotropic support. In severe aci-
daemia (pH < 7.2 and/or base
excess > -12), the abovemen-
tioned measures may be supple-
mented by cautious administra-
tion of intravenous sodium
bicarbonate, initially at doses of
no more than 1 - 2 mmol/kg of
body weight (see information
below).
• Acute poisonings. These
include methanol, ethylene gly-
col, and salicylate poisoning.
Both methanol and ethylene gly-
col are substrates for hepatic
alcohol dehydrogenase and are
metabolised to formic and gly-
colic acids, respectively.
Exposure to toluene, by sniffing
glue, may also cause severe
metabolic acidosis resulting
from the stepwise metabolism of
toluene to benzoic and hippuric
acid. Other poisons known to
cause metabolic acidosis include
ethanol, iron, isoniazid and
strychnine.
Management of the abovemen-
tioned acute poisonings may
require large amounts of sodium
bicarbonate to combat severe aci-
daemia. The role of sodium bicar-
bonate in the management of high
anion gap acidaemia, however, is
controversial. Bicarbonate given in
large quantities may lead to sodium
and fluid overload, to hypokalaemia,
and to ‘alkalosis overshoot’. Regard-
less of whether or not sodium bicar-
bonate is given, the underlying cause
of the acidaemia must be identified
and treated where possible (e.g. man-
agement of ethylene glycol or
methanol poisoning with fomepizole
or ethanol, etc.).
Despite the above reservations, most
experts still recommend the judicious
use of intravenous NaHCO3 in the
management of severe metabolic aci-
dosis (pH < 7.2).
In salicylate poisoning NaHCO3 is
given to alkalinise the urine to
enhance excretion of salicylate (ion
trapping) and is usually not admin-
istered to correct the acidosis.
Although alkaline diuresis increases
the elimination of salicylates and
phenobarbitone, it is clinically dif-
ficult to achieve a urinary pH
above 8 with NaHCO3. In pheno-
barbitone poisoning parenteral
acetazolamide (Diamox) has been
recommended to alkalinise the
urine. Administration of 250 - 500
mg of acetazolamide increases both
urinary pH and urine flow. Urine
pH values may increase to 7.8.
This procedure is, however, not
recommended in salicylate poison-
ing, since it may worsen the central
nervous system effects of poison-
ing. In tricyclic antidepressant
overdose, NaHCO3 is given pri-
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Using sodium bicarbonate in severe metabolic acidosis
NaHCO3 may be given undiluted as a 4.2% solution. However, some
prefer diluting it in 5% dextrose in water or hypotonic (0.45%) saline
solution, depending on the clinical setting. The goal of bicarbonate
therapy is to raise the blood pH to 7.3 and the plasma bicarbonate to 12
- 15 mmol/l. The amount necessary can be calculated using the formu-
la: base excess x 0.3 x body weight (kg), expressed in mmol bicarbonate.
(One ml 8.5 % NaHCO3 = 1 mmol, or 1 ml of 4.2% = 0.5 mmol.) It is
wise to give only two-thirds of the calculated amount initially, and then
reassess the situation. To raise the plasma bicarbonate concentration
from 4 to 8 mmol/l in a 70 kg patient, one should administer 4 x 70 x
0.5, or 140 mmol of sodium bicarbonate. An average dose is 1 - 2
mmol/kg (2 - 4 ml) of a 4.2% solution over 15 minutes. (Several formu-
lae exist to calculate the dose of NaHCO3.)  If acid-base data are not
available 1 - 2 mmol/kg body weight may be given. About 30 minutes
must elapse after the administration of NaHCO3 before its effect can be
judged. It is important to consider the serum calcium level when treat-
ing metabolic acidosis, especially in children. Metabolic acidosis
increases the ionised fraction of total calcium. Treatment of acidosis
decreases the amount of ionised calcium, an effect which may precipi-
tate tetany and/or seizures. The administration of calcium gluconate,
therefore, is sometimes indicated.1,3,5,6
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marily to prevent the development
of cardiac dysrhythmias.
Respiratory acidosis
Respiratory acidosis is a condition
caused by decreased ventilation,
resulting in a low arterial pH, an
elevated PaCO2 and, usually, a
compensatory increase in plasma
HCO3- concentration. Causes
include upper or lower airway
obstruction, status asthmaticus,
severe alveolar defects, ventilatory
restriction, central nervous system
depression and neuromuscular
impairment. The two last-men-
tioned entities are often complica-
tions of overdoses with sedative-
hypnotics (e.g. barbiturates), opi-
oids, tricyclic antidepressants, bot-
ulism and paralytic mussel poison-
ing, to mention a few. In patients
breathing room air a rise in PaCO2
will cause a fall in PaO2, which in
severe cases, may cause hypoxia.
Concomitant hypoxaemia results in
type A lactic acidosis. Manage-
ment is directed towards oxygena-
tion, respiratory support and
removing the underlying cause.4
Respiratory alkalosis
Respiratory alkalosis is a condition
of hyperventilation resulting in an
elevated arterial pH, a low PaCO2
and usually a compensatory
decrease in the plasma HCO3- con-
centration. Salicylate overdose is
known to cause respiratory alkalo-
sis, especially in adults. This is
caused by direct stimulation of the
respiratory centre by salicylates.4,7
WATER AND ELECTROLYTE/
OSMOLALITY 
DISTURBANCES
Poisons, such as digoxin and theo-
phylline in overdose, may cause
electrolyte disturbances directly by
inducing shifts of electrolytes
(especially K+) across cell mem-
branes. Poisons may also cause
water and electrolyte disorders
indirectly, for example by inducing
vomiting and diarrhoea.
Plasma osmolarity
The osmolal concentration of a
solution is called osmolality when
the concentration is expressed as
osmoles per kilogram of water; it is
called osmolarity when it is
expressed as osmoles per litre of
solution.8 The major intracellular
cation is potassium, with a concen-
tration range of 3.3 - 5.3 mmol/l.
The major extracellular cation is
sodium, with a concentration range
of 135 - 147 mmol/l. Normally,
the osmolarity of the extracellular
fluid (280 - 295 mmol/l) approxi-
mates that of the intracellular fluid.
Therefore, the plasma osmolarity is
a convenient guide to intracellular
osmolarity.
The body fluid or plasma osmolar-
ity can be calculated from routine
electrolyte measurements by the
following formula:
A gap greater than 15 mmol/l indi-
cates that an unmeasured osmoti-
cally active solute, e.g. an alcohol,
is present. An elevated osmolal
gap, together with a high anion gap
metabolic acidosis, may indicate
methanol or ethylene glycol poi-
soning.9
Hypokalaemia
Hypokalaemia (< 3 mmol/l) is
often caused by excessive losses of
K+ from the gastrointestinal tract,
as in diarrhoea. Hypokalaemia is
almost invariably present in meta-
bolic alkalosis. Hypokalaemia is
also a complication of theophylline
and beta2-agonist poisoning. This
is caused by the movement of
potassium from the extracellular
fluid into the cell.
Intravenous potassium should be
given slowly, preferably through a
central line, while monitoring the
amplitude of the T-wave of the
ECG (10 ml of a 15% KCl solu-
tion contains 1.5 g potassium chlo-
ride, or 20 mmol of KCl). The
maximum concentration of KCl in
an intravenous solution should
generally not exceed 40 mmol/l. If
higher concentrations are required,
it should be administered in an
ICU.
Hyperkalaemia
Hyperkalaemia  (> 5.5 mmol/l) is
particularly common in oliguric
states (acute renal failure). It is
also associated with rhabdomyoly-
sis (often a complication of acute
poisoning). Hyperkalaemia is also
a major feature of severe metabolic
acidosis (due to movement of
potassium out of the cells to the
extracellular fluid). Hyperkalaemia
may also be associated with an
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Calculating body fluid or
plasma osmolality
2 x [Na+] + [urea] + [glucose]
in mmol/l  (calculated osmolari-
ty)
The osmolal gap = measured
osmolarity - calculated osmolar-
ity. The normal range is 10 - 15
mmol/l 
(A slightly modified formula
includes the plasma potassium
concentration:
2 x [Na+ + K+]  +  [urea]  +
[glucose]
For this formula a gap > 10
mmol/l indicates unmeasured
osmotically active solute.)
Correcting severe
hypokalaemia
To correct severe hypokalaemia,
adequate urine flow should be
ensured, and then potassium
should be administered by
adding 30 mmol to each litre of
fluid. The amount of potassium
needed can also be calculated
using the following formula:
(desired K+ - measured K+) x 0.3
x weight in kg
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overdose of certain drugs that
inhibit membrane ion pumps
(Na+/K+ATPase), an effect which
may lead to a shift of potassium
from inside the cell to the extracel-
lular fluid (e.g. digoxin). Other
poisonous substances associated
with hyperkalaemia include fluo-
ride (opening of potassium chan-
nels), cyanide (depletion of adeno-
sine triphosphate), ingestion of
potassium salts and lithium (in
cases where lithium produces renal
tubular toxicity).
Management of hyperkalaemia
according to serum levels and/or
ECG changes, includes the follow-
ing measures:
• Mild hyperkalaemia (6.0
mmol/l) may respond to dimin-
ished intake (1/2 Darrow’s solu-
tion should be avoided in chil-
dren). Sodium bicarbonate can
be given if the patient is acidotic.
The acid-base status should be
monitored. A loop diuretic
(furosemide 1 - 5 mg/kg) may
also enhance renal potassium
excretion. A plasma potassium
level above 6.0 mmol/l requires
the administration of sodium
polystyrene sulfonate (Kexelate,
formerly known as Kayexelate).
The dose in adults is 15 - 30 g
orally or 30 - 50 g by retention
enema, repeated 6 hourly as
needed, and in children 1 - 2
g/kg/dose. The oral route is
more effective although some
clinicians prefer a high-retention
enema. The onset of action is
usually within 30 - 60 minutes.
• More severe cases of hyper-
kalaemia (potassium ≥ 7mmol/l)
require Kexelate as well as other
more aggressive and rapid-act-
ing measures, including:
• Insulin/glucose regimen.
The ratio is 1 U insulin per 2
g glucose. The average dose
of insulin is 5 - 10 U of regu-
lar insulin given by intra-
venous push, combined with
20 - 40 ml of 50% glucose.
The onset of action is usually
within 30 minutes. This
should be followed by 10%
dextrose/H2O at 50 ml/h to
prevent hypoglycaemia. The
recommended paediatric dose
of 50% dextrose/water is 
1 - 2 ml (0.5 - 1.0 g)/kg
intravenously over 30 minutes
(50 ml of a 50% ampoule
contains 25 g dextrose). To
this solution is added 1 U of
soluble insulin per 5 gram
dextrose, or 0.1 U to 1 ml
(0.5 g) 50% dextrose. Blood
glucose levels should be mon-
itored regularly. (Some pae-
diatricians use the glucose/
insulin regimen only if other
measures fail, or in cases
where potassium levels are
between 9 and 10 mmol/l.
• Raising the pH, either with
NaHCO3 or by hyperventila-
tion, where applicable. The
effectiveness of empirical
administration of NaHCO3
for the treatment of life-
threatening acute hyper-
kalaemia has recently been
questioned.
• Salbutamol therapy, by
inhalation or the intravenous
route. The inhalation (nebu-
lisation) dose in adults is 10 -
20 mg (5 mg/ml solution)
over 10 minutes. In children
the recommended inhalation
dose is 2.5 - 5 mg over 20
minutes by nebulisation. The
intravenous dose is 4 µg/kg in
both adults and children.
The effect lasts for 2 - 4
hours. The use of salbutamol
should only be implemented
as adjunctive therapy to other
more traditional treatment
modalities. It appears to be a
safe and reasonably effective
means of treatment. It may
be used as an interim mea-
sure while waiting for dialysis
or other potassium-removing
therapies to be instituted.
• Haemodialysis should be
considered if the above mea-
sures fail. It could take a few
hours to start a dialysis pro-
cedure. Other treatment
modalities, therefore, should
be carried out even if dialysis
is anticipated.
• Note. The intravenous
administration of 10 - 20 ml
of 10% calcium gluconate
(over 5 - 10 minutes, and
under ECG control) should
be reserved for the manage-
ment of the cardiodysrhythmic
and cardioplegic effects of
hyperkalaemia. However, if
the patient initially presents
with cardiac dysrhythmias
due to hyperkalaemia, the
administration of calcium
should be a priority.
Paediatricians tend to admin-
ister calcium earlier, especially
if the serum calcium is
decreased. The recommended
paediatric dose of 10% calcium
gluconate solution is 0.5 - 1
ml/kg at a rate of 1.0 ml/min.
Pulse rate is a useful parameter
to guide the dose. Caution
should be employed when giv-
ing calcium to patients on
digoxin, because of the risk of
precipitating hypokalaemia-
related dysrhythmias.
Hypernatraemia and hypo-
natraemia
Hypernatraemia and hypo-
natraemia are uncommon in acute
poisoning/drug overdose.
Hyponatraemia (< 130 mmol/l),
however, has been reported to
occur in certain cases of snakebite
(e.g. berg adder and other minor
adder bites). The cause is not
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Hypernatraemia and
hyponatraemia are
uncommon in acute
poisoning/drug
overdose.
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known, but it is probably not due
to excessive secretion of antidiuret-
ic hormone. Severe hyponatraemia
(< 120 mmol/l) may cause convul-
sions.
Management of hyponatraemia
includes the restriction of water
and the administration of sodium if
serum levels are < 130 mmol/l in
cases of inappropriate ADH secre-
tion.
Hypocalcaemia (see block)
Hypocalcaemia is a known compli-
cation of fluoride poisoning. It is
also associated with ethylene glycol
poisoning. (The normal total
serum calcium is 2.05 - 2.56
mmol/l, the ionised calcium is 1.1 -
1.3 mmol/l and the protein-bound
calcium is 0.9 - 1.1 mmol/l.)  In
severe cases intravenous calcium
gluconate is indicated (see block).
Hypoglycaemia
Coma and convulsions resulting
from hypoglycaemia occur occa-
sionally in acute poisonings.
(Normal random serum glucose is
4.1 - 11.1 mmol/l.) The sulphonyl-
ureas (oral antidiabetic agents),
insulin and ethanol are implicated in
most cases. Hypoglycaemia may also
be a complication of severe paraceta-
mol and Amanita phalloides poisoning
due to liver failure. After correction
of hypoglycaemia with 50% dex-
trose/H2O, a continuous infusion of
20% glucose should be administered
to prevent relapse.4
References available on request.
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The use of intravenous calci-
um gluconate in severe
hypocalcaemia
In acute symptomatic hypocal-
caemia the intravenous dose is
10 ml of a 10% calcium glu-
conate solution, at a rate not
exceeding 5 ml/min, repeated
once, if necessary. Thereafter,
10 ml of 10% calcium gluconate
per litre of 5% dextrose/H2O at a
rate of 50 - 100 ml/h. The pae-
diatric dose is one-half of the
adult dose. Hypocalcaemia is
common in children in acute
renal failure, and calcium levels
may decrease precipitously to
very low levels in rhabdomyoly-
sis (phosphate levels may at the
same time be elevated).
The amount of sodium needed to replace the deficit can be cal-
culated (if 130 mmol is your aim) as follows:
(130 - measured Na+) x 0.6 x weight in kg. This formula gives the
deficit in mmol. The administration of 40 ml normal saline per kg
should raise the serum sodium by 10 mmol/l. If fluid has to be restricted,
a 5% NaCl solution may be used (1.17 ml of a 5% NaCl solution is
equal to 1 mM). Hypertonic (5%, 850 mmol/l) saline should be
administered by a central line. It is recommended to give half the cal-
culated dose of sodium, and then according to follow-up levels. In the
management of acute hyponatraemia it is advisable to administer sodi-
um until the symptoms (convulsions) disappear and not until the serum
sodium is normal. (NaHCO3 solution (4.2%) may also be utilised as a
source of sodium.)   Note: As a general guideline it is recommended
that the serum sodium not be allowed to increase by > 0.5 mmol/l/h in
chronic hyponatraemia (not > 2 mmol/l in 4 hours), or > 1 mmol/l/h
(not > 4 mmol/l in 4 hours) in acute hyponatraemia. (Hyponatraemia of
more than 36 - 48 hours’ duration is considered chronic.)   Serum sodi-
um levels should be monitored at least 4 hourly. Inappropriate rapid
correction of serum sodium may produce central pontine myelinosis.
IN A NUTSHELL
Acid-base and potassium abnor-
malities are common in poison-
ing.
Poisoning should be excluded in
cases of unexplained metabolic
acidosis.
Major adverse consequences of
severe acidaemia include
decreased cardiac output,
decreased arterial blood pres-
sure, reduction in the threshold
for cardiac dysrhythmias, and a
decrease in hepatic and renal
blood flow. 
The anion gap is increased in
cases of ketoacidosis, lactic aci-
dosis, and other forms of acidosis
in which organic anions are
increased, as in methanol and
ethylene glycol poisoning.
SINGLE
SUTURE
A little of what you fancy ...
As drinking and abstinence
behaviour changes over time,
some view the conventional J-
shaped mortality curve
(which depicts abstainers and
heavy drinkers as having a
higher mortality risk than
those who indulge moderate-
ly) with scepticism. When
researchers prospectively
studied the relation by using
two measurement points, they
found that risk for consistent
abstainers was not raised, but
for men who consistently
drank heavily the all-cause
mortality risk was higher.
Abstainers who started drink-
ing did not improve their sur-
vival rate; heavy drinkers who
reduced consumption did.
Journal of Studies on Alcohol 2003; 64:
278-285 (from Minerva. BMJ 2003;
326: 1274.)
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